Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease

Clinical trial NCT05926011 · RECRUITING

Trial details

NCT number: NCT05926011
Sponsor: REGEnLIFE SAS
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2023-07-24
Primary completion: 2027-06-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.